On March 3, 2025, the Food and Drug Administration (FDA) issued FDA Advisory No. 2025-0139 announcing new email addresses for submitting notifications and reports on health product recalls.
Market Authorization Holders (MAHs) must promptly notify the FDA and submit the necessary reports and information to the Food and Drug Action Center (FDAC) at info@fda.gov.ph. Additionally, MAHs must copy the Office of the Director General (ODG) at odg@fda.gov.ph and the relevant centers using the following email addresses:
| CENTER | E-MAIL ADDRESS |
|---|---|
| Center for Drug Regulation and Research (CDRR) | cdrr.recall@fda.gov.ph |
| Center for Food Regulation and Research (CFRR) | Cfrr.recall@fda.gov.ph |
| Center for Cosmetics and Household/Urban Hazardous Substances Regulation and Research (CCHUHSRR) | cchuhsrr.recall@fda.gov.ph |
| Center for Device Regulation, Radiation Health, and Research (CDRRHR) | cdrrhr.recall@fda.gov.ph |
Implications for Stakeholders:
The updated email addresses streamline the notification process for health product recalls, ensuring that reports are directed to the appropriate centers for timely action.
For more information, refer to the official advisory: FDA advisory page.
For inquiries, contact us at sales@andamanmed.com or click the button below.
